ProBiotix Health #PBX – Publication of Circular and Notice of Requisitioned General Meeting

Further to the Company’s announcement on 25 September 2024, ProBiotix Health plc, the life sciences business developing probiotics to support cardiometabolic health, announces that today it will be publishing a circular to Shareholders (the “Circular”) containing details of a requisitioned general meeting of the Company (the “Requisitioned General Meeting”). The Requisitioned General Meeting will be […]

Tekcapital #TEK investee company Belluscura #BELL – Half year results to June 2022 and new agreement with US distributor

Belluscura #BELL Half year results to June 2022 and new agreement with US distributor. Significant progress with best-in-class product launches, securing manufacturing capacity and expanding our market Financial highlights – record revenue ·      Group revenue of $0.6 million (H1 2021: $nil); a 34% increase over H2 2021. ·      Adjusted EBITDA of $5.1 million loss (H1 […]